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SALZBERG AND GRIFFIN (1952) have indicated that rats which were highly
susceptible to alloxan were resistant to the action of carcinogenic dyes producing
hepatomas. Later Bielschowsky and Bielschowsky (1959) also demonstrated
that rats in which severe diabetes had been produced by the injection of alloxan,
were resistant to the effects of aminofluorene and acetyl derivatives of amino-
fluorene. Shrivastava and Quastel (1962) showed in their in vitro studies that
when Ehrlich ascites cells were incubated with rat brain cortex slices, in the
presence of 5 mm glucose concentration, the latter were preferentially depleted
of glutamine which was used by the tumour cells. These workers also showed
that the presence of 10 mm or higher glucose concentrations inhibited the leakage
of this amide from the normal tissue. Recently Wu, Roberts and Baur (1965)
have reported lower levels of glutamine in various tissues of animals injected
with some fast growing tumours like Walker 256 caroinosarcoma and Novikoff
hepatoma. They have also found that the levels of this amide in the animals
having Morris hepatoma 7800, which is a very slow growing tumour, was normal
until the tumour attained a big size.
The results presented in this paper indicate that the animals which were fed
with 8% glucose did not develop tumours and that their tissue glutamine levels
were normal.
MATERIALS AND METHODS
Tumour
A strain ofmouse fibrosarcoma (MFS) produced by Waravdekar and Ranadive
(1957) was obtained from the Indian Cancer Research Centre, Bombay, and
maintained in Swiss inice in our laboratories. The animals were injected sub-
cutaneously with 0-2 ml. of 1: 5 (w/v) tumour suspension in physiological saline.
All animals were kept on a stock diet (freshly prepared every day) containing
the following ingredients: wheat flour 66%0!, Bengal gram 5%, skimmed milk
powder 20%, refined ground nut oil 5%, refined groundnut oil fortified with
vitamins A and D 1/ (the final amount of vitamins A and D are 3000 i.u. and
300 i.u. respectively per g. food), yeast powder 2%, calciam carbonate 0.5% and
sodium chloride 0.5%/. 25 g. ofthe above mixture was given per mouse per day;
mice receiving glucose supplements were fed stock diet mixed with 8% glucose.
The glucose feeding was started the day after the transplantation of tumours
and continued for 10-12 days.GLUCOSE FEEDING AND TUMOUR DEVELOPMENT
Amino Acid determinations
The animals were killed on the 11th day after the tumour transplantation
and skin surrounding the tumour was placed in 2-0 ml. of 95% ethanol. Skin
away from the tumour was also taken and treated in the same way. In animals
where there was no tumour growth, the skin from the site of injection was taken
in 2*0 ml. of 95% ethanol. Tissues were homogenised in ethanol, and free amino
acid extraction and determinations were carried out according to the method
of Kinii and Quastel (1959), using Whatman No. 3 filter paper. The amino acid
spots were detected by sprayinlg the chromatograms with 0.25% ninhydrin in
acetone and keeping the paper in an oven at 80° C. for a few minutes.
Glutambine determination
Mice were given mild ether anaesthesia and blood was obtained from the
heart, with the help of a syringe rinsed with heparin, and collected in a centrifuge
tube. Plasma was separated by centrifugation at 2000 r.p.m. for 5 minutes in
a clinical centrifuge. I 0 ml. plasma was then deproteinised with the addition
of tungstic acid (Gray et al., 1960).
Samples of skin, liver and brain were taken in 1 g. quantities and, wherever
needed, samples from more than one animal were pooled to get the required
amount. The samples were minced with scissors and kept in 10 ml. 80% ethanol
for about 1 hour at room temperature. The ethanolic extracts were dried com-
pletely and resuspended in 4-8 ml. H20. To this were added 0-68 ml. 0-6 N
H2SO4 and 0O5 ml. 10% sodium tungstate solutions. The protein free filtrates,
obtained from either plasma or other tissues, were passed through a column of
Dower-1-X 8, to obtain pure glutamine samples (Olsen, Hill and Branion 1962).
Microbiological determinations of glutamine were carried out using Lactobacillus
plantarum, obtained from National Chemical Laboratories, Poona, according to
the method described by Olsen et al. (1962).
Blood glucose estimations were carried out according to the method of Folin
and Wu (1962).
RESULTS
Effect ofglucose on tumour growth
It was observed that the majority of the mice kept on the diet supplemented
with 8% glucose per day did not develop any tumour even after 10-12 days of
transplantation. It may be seen from Table I that in the injection control
groups only 5% of the animals did not develop any tumour, but in the glucose
fed group 70% of the mice did not show any tumour growth. It may further be
observed that in the latter group none ofthe animals showed any big size tumour
although in the control groups 77.5% of the animals showed big growth. The
weight of the big tumours were about i of the body weight of the mouse. In
TABLE I.- Effect of Glucose Feeding on Tumour Development
Type ofanimal Number ofanimals No growth Small Medium Big
Control (MFS injected) . 40 * 2 (5%) * 4 (10%) . 3 (7.5%) .31 (77.5%)
MFS injected, glucose fed . 60 . 42 (70%) . 12 (20%) . 6 (10%) . Nil
All observations made 10-12 days after transplantation.
Figures in parentheses indicate percent of total number of animals used.
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cases where the animals kept on glucose diet did develop tumours, the growth
was about A-5- of the body weight of the animal. An idea of the size difference
between the tumours can be had from Fig. 1.
Amino acid patterns
The free amino acid pattern of the skin immediately surrounding the tumour
growth differed from the one obtained fronn animals transplanted with MFS and
kept on glucose diet. The former did not show any trace of glutamine while the
latter showed a spot of this amide (Fig. 2, 3).
Glucose levels
It can be seen from Table 1I that the average fasting blood glucose level of
iiormal mice was 115 + 15 mg./100 ml., and that of tumour bearing inice was
TABLE II.- Blood Glucose Levels in Tumour-bearing Mlice
Blood glucose*
Animals (mg./100 ml. blood)
Normal
(No tumour implanted) . 115 1 15
MFS bearing . . 75 ± 10
Gltucose fed
(Injected with MFS) . 128 ± 20
Normal
(Glucose fed) 122 ± 15
* Blood was taken 24 hours after intake of food.
The values represent an average of 20 animals in each set.
75 ± 10 mg./ml. It was observed that the animals whiclh had been injected
with tumours and were kept on the glucose diet showed a higher fasting blood
glucose value (128 i 20 mg.00) than the normal controls. Some determinations
were also made to see if feeding of glucose with the food brings about an inierease
in the blood sugar level and the period for which it could be maintained. It
may be observed from Fig. 4 that within 2 hours of giving the food mixed with
glucose the blood sugar increased, and that even after 24 hours the value remained
higher than the normal control. But in the case of the animals kept on stock
diet the blood sugar level came down to values below the initial level within 6
hours after the food was given. The same initial blood glucose level in both
cases was due to the fact that, for these determinations, normal animals were
EXPLANATION OF PLATE.
Fia. 1. Shows the difference in tumour size in animals, 12 days after the injection of MFS.
(1) Tumour from control animal. (2) Tumour from animal fed diet supplemented with 8%
glucose.
FIG. 2. Chromatogram of the free amino acids from the skin surrounding the tumour growth
from the control animals. Note the absence of glutamine spot.
FIG. 3. Chromatogram of the free amino acids from the skin from the site of injection of
tumour tissue, obtained from the animals fed diet sup)plemented with 8% glucose. Note
the presence of the spot of glutamine (GINH2).
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FIG. 4.-Effect of glucose feeding on the blood sugar levels of mice.
oD O Glucose fed; 0-* Stock diet.
For details see text.
taken from the animal house colony. A total of 15 animals were used in each
set and the values plotted are an average of the values obtained at each point.
The variations were within about 10-15%.
Glutamrine levels
It may be seen from Table III that the levels of glutamine in plasma, liver,
skin and brain of tumour-bearing mice were much lower than those obtained in
the normal animals. The values for the animals injected with tumour and kept
on a diet containing glucose were nearer to or higher than those obtained in the
case ofnormal animals.
TABLE III.-Free Glutamine Levels in Tissues ofTumour-bearing Mice
Animals Plasma* Livert Skint Braint
Normal . . . 4,875 ± 500 . 9,000 ± 1,200 . 9,375 ± 1,645 . 16,125 ± 1,100
(Uninjected)
MFS bearing . . 2,322 ± 175 3,750 i 250 . 1,256 ± 135 . 12,000 ± 500
Glucose fed . 3,125 ± 123 7,875 + 637 . 10,500 ± 790 . 18,750 i 2,000
(Injected with MFS)
* Values indicated are y glutamine/100 ml. plasma.
t Values indicated are y glutamine/100 g. wet weight tissue.
All values represent average of 20 animals in each set.
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DISCUSSION
It seems probable from the results presented here that the feeding of glucose
may have an inhibitory effect on the growth of tumour in mice, injected with
MFS. This probability is further substantiated by the fact that when the feeding
of glucose was stopped, in mice which did not develop tumours even after 10-12
days of transplantation, there was an appearance of the neoplastic growth which
attained a big size in about 10 days. This may indicate that the presence ofhigh
or near normal blood sugar level is keeping the tumour cells in a dormant stage.
The discrepancy between the qualitative and quantitative data (cf. Fig. 2 and
Table III) for the skin glutamine level may be due to the fact that whereas in the
former case a small amount of skin immediately surrounding the tumour was
taken, in the latter the whole skin of the body was used. The results of free
amino acid patterns of skin obtained from the two sets of animals, coupled with
the relationship between levels of glutamine and tumour growth, may indicate
the possible role of glutamine leakage and development of tumour in the mice.
It may be indic.ated here that the low levels of glutamine observed in tumour-
bearing animals was not due to a low intake of food, as the amount given to the
ailimals was consumed within 24 hours irrespective of the tumour growth.
There have been reports that the arterio-venous glucose levels are low in
animals having tumour growth (Cori and Cori, 1925, 1926). Later Goranson and
Tilser (1955) also reported a relatively low blood sugar concentration in tumour-
bearing animals. Our own results also show a much lower value for glucose in
the blood of tumour-bearing mice. It is possible that, due to a low glucose level
in the body, glutamine is leaking out of the host tissues, thereby meeting the
high metabolic requirements of the tumour tissues for this amide (Eagle, 1955;
Rabinovitz, Olsen and Greenberg, 1956; Roberts and Tanaka, 1956; Roberts
et al., 1956). That such a situation does exist under in vitro conditions has
already been reported (Shrivastava and Quastel, 1962). Wu and Baur (1960)
have also reported that glutamine level decreases gradually with the increase in
the size of tumours having high glycolysing capacity.
The probable reason why the animals transplanted with tumour and kept on
a glucose supplemented diet did not develop any tumour may be due to the fact
that glucose is being ingested by the animals regularly over a period of 24 hours,
thereby maintaining the blood glucose concentration at above or near the normal
range. The leakage of glutamine from the host tissues into the blood stream
may thus be inhibited, thereby starving the transplanted tumour cells of an
essential growth factor. This may also explain the failure of previous workers
(Salzberg and Griffin, 1952; Bielschowsky and Bielschowsky, 1959) to obtained
tumour growth in animals made diabetic with alloxan injections. It may be
added here that similar results, as reported in this paper, have also been obtained
with rats and mice injected with Yoshida sarcoma (solid) and Schwartz tumours,
respectively, in our laboratories.
SUMMARY
Swiss mice injected with a fibrosarcoma were fed with 8% glucose mixed
with food. Unlike the injected control groups, the animals kept on a glucose
supplemented diet did not show any tumour development. No glutamine spot
could be detected in the chromatograms obtained from the tissue surrounding
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the malignant growth whereas in those from the skin away from the tumour
or from the site of injection, in the glucose fed groups, showed its presence.
Glucose feeding not only increased the blood sugar concentration but also main-
tained a normal level of glutamine. Both the blood sugar and glutamine levels
were lower in mice injected with tumour and kept on glucose-free diet.
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